天天彩票投注


 

 

SINCE1989

Shenzhen Kexing Biotech Co., Ltd.

Shenzhen Kexing Biotech Co., Ltd.

 

Shenzhen Kexing Biotech Co., Ltd., engaged in R&D, manufacture and sales of biological medicine, was invested and founded in 1989 by bioengineering center of State Scientific and Technological Commission, and Virology Research Institute of Chinese Academy of Preventive Medicine, , Shanghai and Changchun Biological Products Institute of Ministry of Health. In 2008, Kexing Biotech was reorganized and then formally acquired and fully managed by Genzong Group, became the important strategy unit of Genzong Group.

The hit product of the company -SINOGEN (Recombinant Human Interferon α1b) has 6 specifications, becoming the interferon product with most specifications. Interferon α1b is the first choice medicine for curing chronic hepatitis B and C, hairy cell leukemia. SINOGEN is in first position of curative effect, frequency of use, market share, popularity, and fame at home and abroad, becoming the first brand of China interferon market, and rated as key promotion project by China Medical association.

In 2014, after building the new pharmaceutical base, the annual production capacity of interferon increased to 100 million vials. At present, the products have covered the main hospitals in core cities and core hospitals in main cities of provinces all over the country besides Tibet. With the reform of Urban medical and health system and medical insurance system, the company will continue expand the market from provinces and cities to counties and towns, and spread deeper downwards.

Shenzhen Kexing takes the improvement of China bioengineering industry as its mission, development of new type bioproducts and enhancement of human health as its goal. Over 20 years of development, Kexing has gained many honors: In1996, Kexing was recognized by the State Council as the largest industrial base for genetic engineering drugs in China. In1997, Kexing was rated as Important High Technology Enterprise of Shenzhen; In 2000, Kexing was listed by the Ministry of Science and Technology as one of the first batch industrialization bases of National "863" Plan.

 

Project cooperation

Continue to understand >